Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report
Medicina · 17.06.2024 · 60 (6) · 992
DOI: 10.3390/medicina60060992 ↗Kurz gefasst
Fallbericht in der Zeitschrift Medicina, online erschienen am 17.06.2024. Verfasst von Jaeha Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Kyung Hee University Hospital, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Carboplatin, Lung Neoplasms, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Platinum-based combination chemotherapy, including cisplatin and carboplatin, are important cytotoxic anti-cancer agents that are widely used to treat various solid tumors. Carboplatin has a similar effect on survival in small cell lung cancer, but generally has a milder toxicity profile when compared with cisplatin. Both may cause moderate or severe neurotoxicity, but ocular neurotoxicity from carboplatin is rarely reported. Case presentation: A 79-year-old man underwent intravenous polychemotherapy (atezolizumab, etoposide, and carboplatin) for small cell lung cancer. One week after the second cycle of chemotherapy, he reported bilateral visual loss as hand motion in both eyes. Dilated fundus examination showed retinal arterial narrowing without hemorrhage, and diffuse choroidal and retinal thinning was observed in an optical coherence tomography scan. Fluorescein angiography revealed significantly delayed circulation without evidence of obstructive lesions. 30-Flicker electroretinogram testing showed a complete absence of cone response in both eyes. The patient’s visual acuity aggravated to no light perception in both eyes, even after the cessation of chemotherapy.
Conclusions
Carboplatin combination chemotherapy administered at therapeutic doses can result in irreversible visual loss, a side effect that is not widely acknowledged. When using carboplatin, physicians should be aware of its potential ocular toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Kyung Hee University Hospital, Kyung Hee University, Seoul 02447, Republic of Korea.
ORCID-Profile: Kiyoung Kim
Zitieren
APA
Kim, J., Lee, J., Lee, S., & Kim, K. (2024). Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report. Medicina, 60(6), 992. https://doi.org/10.3390/medicina60060992
Vancouver
Kim J, Lee J, Lee S, Kim K. Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report. Medicina. 2024;60(6):992. doi:10.3390/medicina60060992
BibTeX
@article{Kim2024,
author = {Kim, Jaeha and Lee, Junwoo and Lee, Seungyeon and Kim, Kiyoung},
title = {Bilateral Visual Impairment following Combination Chemotherapy with Carboplatin in Patients with Small Cell Lung Cancer: A Case Report},
journal = {Medicina},
year = {2024},
volume = {60},
number = {6},
pages = {992},
doi = {10.3390/medicina60060992}
}
EUVIMED